Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of Jan-05-2024

  1. MiMedx Group Inc

    World Rank (Jan-05-2024)
    7,947
    Market Cap (Jan-05-2024)
    1.139 Billion USD
    World Rank (Jul-30-2023)
    9,160
    Market Cap (Jul-30-2023)
    0.921 Billion USD
    World Rank (Dec-25-2022)
    15,405
    Market Cap (Dec-25-2022)
    0.315 Billion USD
    World Rank (Jan-07-2022)
    11,989
    Market Cap (Jan-07-2022)
    0.63 Billion USD
    Annual Revenue in USD
    267 Million USD
    Annual Operating Income in USD
    -25 Million USD
    Annual Net Income in USD
    -37 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ OTC
    Company Profile

    Mimedx Group Annual Total Revenue for year ending Dec-2022 was 267 million USD and and Net loss for year ending Dec-2022 was -36 million USD.

    MiMedx Group Annual Total Revenue for year ending Dec-2021 was 258 million USD and and Net loss for year ending Dec-2021 was -16 million USD.

    As on 2022, MiMedx Group has 867 employees.

    Facts About Company

    Mimedx Group Annual Total Revenue for year ending Dec-2022 was 267 million USD and and Net loss for year ending Dec-2022 was -36 million USD.

    Company Website
    MIMEDX GROUP

  2. Belite Bio Inc

    World Rank (Jan-05-2024)
    7,954
    Market Cap (Jan-05-2024)
    1.137 Billion USD
    World Rank (Jul-30-2023)
    11,043
    Market Cap (Jul-30-2023)
    0.656 Billion USD
    World Rank (Dec-25-2022)
    9,808
    Market Cap (Dec-25-2022)
    0.768 Billion USD
    Headquarters Country
    USA
    Company Profile
    Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on aging metabolic diseases including dry age related macular degeneration, liver disease and diabetes. The headquarters is in United States.
    Company Website
    Belite Bio Inc

  3. Geron Corporation

    World Rank (Jan-05-2024)
    7,962
    Market Cap (Jan-05-2024)
    1.135 Billion USD
    World Rank (Jul-30-2023)
    6,549
    Market Cap (Jul-30-2023)
    1.618 Billion USD
    World Rank (Dec-25-2022)
    9,612
    Market Cap (Dec-25-2022)
    0.797 Billion USD
    World Rank (Jan-07-2022)
    15,170
    Market Cap (Jan-07-2022)
    0.38 Billion USD
    Annual Revenue in USD
    1 Million USD
    Annual Operating Income in USD
    -138 Million USD
    Annual Net Income in USD
    -141 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Geron Corporation is a Late Stage Clinical Biopharmaceutical company focused on the development and potential commercialization of a first in class telomerase inhibitor, imetelstat, an innovative therapeutic for hematologic myeloid malignancies. The headquarters is in USA.

    Facts About Company

    Geron Corporation Annual Total Revenue for year ending Dec-2022 was 0.5 million USD and and Net loss for year ending Dec-2022 was -141 million USD.

    Geron Corporation Annual Total Revenue for year ending Dec-2021 was 1.3 million USD and and Net loss for year ending Dec-2021 was =116 million USD.

    As on 2022, Geron Corporation has 107 employees.

    Company Website
    GERON CORPORATION
    Wikipedia
    Wikipedia

  4. Amylyx Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    8,008
    Market Cap (Jan-05-2024)
    1.123 Billion USD
    World Rank (Jul-30-2023)
    6,840
    Market Cap (Jul-30-2023)
    1.514 Billion USD
    World Rank (Dec-25-2022)
    4,858
    Market Cap (Dec-25-2022)
    2.356 Billion USD
    World Rank (Jan-07-2022)
    8,733
    Headquarters Country
    USA
    Company Profile
    Amylyx Pharmaceuticals Inc is a pharmaceutical company that is dedicated to the development of potential therapies for neurodegenerative diseases. The headquarters is in United States.
    Company Website
    AMYLYX PHARMACEUTICALS, INC.

  5. Soleno Therapeutics

    World Rank (Jan-05-2024)
    8,024
    Market Cap (Jan-05-2024)
    1.119 Billion USD
    World Rank (Jul-30-2023)
    24,771
    Market Cap (Jul-30-2023)
    0.055 Billion USD
    World Rank (Dec-25-2022)
    31,050
    Market Cap (Dec-25-2022)
    0.012 Billion USD
    World Rank (Jan-07-2022)
    27,428
    Market Cap (Jan-07-2022)
    0.04 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -25 Million USD
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    SOLENO THERAPEUTICS

  6. Pliant Therapeutics Inc.

    World Rank (Jan-05-2024)
    8,026
    Market Cap (Jan-05-2024)
    1.119 Billion USD
    World Rank (Jul-30-2023)
    8,672
    Market Cap (Jul-30-2023)
    1.013 Billion USD
    World Rank (Dec-25-2022)
    9,003
    Market Cap (Dec-25-2022)
    0.888 Billion USD
    World Rank (Jan-07-2022)
    13,818
    Market Cap (Jan-07-2022)
    0.47 Billion USD
    Annual Revenue in USD
    10 Million USD
    Annual Operating Income in USD
    -127 Million USD
    Annual Net Income in USD
    -123 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Company Profile
    Pliant Therapeutics is a Clinical Stage Biopharmaceutical company focused on the developing new treatments for fibrotic diseases. The company estimated annual revenue is currently 18.9 million USD per year. The headquarters is in USA.
    Company Website
    PLIANT THERAPEUTICS, INC.

  7. Zentalis Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    8,087
    Market Cap (Jan-05-2024)
    1.106 Billion USD
    World Rank (Jul-30-2023)
    5,954
    Market Cap (Jul-30-2023)
    1.885 Billion USD
    World Rank (Dec-25-2022)
    8,174
    Market Cap (Dec-25-2022)
    1.043 Billion USD
    World Rank (Jan-07-2022)
    4,662
    Market Cap (Jan-07-2022)
    3.16 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -227 Million USD
    Annual Net Income in USD
    -236 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Zentalis Pharmaceuticals is a Clinical Stage Biopharmaceutical company. It is discovery and development of small molecule therapeutics targeting fundamental biological pathways of cancer. The headquarters is in USA.
    Facts About Company
    The company annual revenue is 7.1 million USD and 71 employees as on 2020.
    Company Website
    ZENTALIS PHARMACEUTICALS, INC.

  8. Collegium Pharmaceutical

    World Rank (Jan-05-2024)
    8,100
    Market Cap (Jan-05-2024)
    1.103 Billion USD
    World Rank (Jul-30-2023)
    10,025
    Market Cap (Jul-30-2023)
    0.785 Billion USD
    World Rank (Dec-25-2022)
    9,777
    Market Cap (Dec-25-2022)
    0.771 Billion USD
    World Rank (Jan-07-2022)
    11,744
    Market Cap (Jan-07-2022)
    0.66 Billion USD
    Annual Revenue in USD
    463 Million USD
    Annual Operating Income in USD
    33 Million USD
    Annual Net Income in USD
    -25 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Collegium Pharmaceutical is a Specialty Pharmaceutical company committed to being the leader in responsible pain management. It has been focused on developing and commercializing new medicines for pain management that reflect its core values and commitment to people suffering from pain, providers and communities. The headquarters is in USA.

    Company Website
    COLLEGIUM PHARMACEUTICAL

  9. Alpine Immune Sciences

    World Rank (Jan-05-2024)
    8,232
    Market Cap (Jan-05-2024)
    1.075 Billion USD
    World Rank (Jul-30-2023)
    11,771
    Market Cap (Jul-30-2023)
    0.585 Billion USD
    World Rank (Dec-25-2022)
    15,748
    Market Cap (Dec-25-2022)
    0.299 Billion USD
    World Rank (Jan-07-2022)
    16,596
    Market Cap (Jan-07-2022)
    0.31 Billion USD
    Annual Revenue in USD
    30 Million USD
    Annual Operating Income in USD
    -58 Million USD
    Annual Net Income in USD
    -58 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    ALPINE IMMUNE SCIENCES

  10. Innoviva

    World Rank (Jan-05-2024)
    8,240
    Market Cap (Jan-05-2024)
    1.075 Billion USD
    World Rank (Jul-30-2023)
    9,507
    Market Cap (Jul-30-2023)
    0.861 Billion USD
    World Rank (Dec-25-2022)
    8,769
    Market Cap (Dec-25-2022)
    0.924 Billion USD
    World Rank (Jan-07-2022)
    8,422
    Market Cap (Jan-07-2022)
    1.22 Billion USD
    Annual Revenue in USD
    331 Million USD
    Annual Operating Income in USD
    206 Million USD
    Annual Net Income in USD
    213 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Innoviva is a Pharmaceutical company with a portfolio of royalties that include respiratory assets partnered with Glaxo Group Limited. The headquarters is in USA.
    Company Website
    INNOVIVA INC

Share